Origin Asset Management LLP Amgen Inc Transaction History

Origin Asset Management LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $467,160 - $518,280	-2,000 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $44,382 - $51,720	-200 Reduced 9.09%	2,000 $498,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $398,905 - $443,615	-1,700 Reduced 43.59%	2,200 $559,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $118,686 - $145,644	-600 Reduced 13.33%	3,900 $920,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $838,304 - $1.11 Million	-4,600 Reduced 50.55%	4,500 $912,000

Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $1.72 Million - $2.21 Million	9,100 New	9,100 $2.19 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $8.34 Million - $9.74 Million	-49,205 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $1.69 Million - $1.89 Million	-10,000 Reduced 16.89%	49,205 $8.56 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $9.9 Million - $11.3 Million	59,205	59,205 $11 Million

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Origin Asset Management LLP with notifications on news.